Medis is proud to actively support the prospective PIONEER-IV Study
The Medis QFR® software is being used in all the centers that are participating in the PIONEER-IV Study with P.I. by Prof. Serruys at the Galway University in Ireland. Currently a total of 16 sites are active from Ireland, the UK, the Netherlands, Belgium and Spain, with more sites to be activated soon.
The PIONEER-IV is a prospective, single-blind (patient), randomized, 1:1, controlled, multi-center study comparing clinical outcomes between angiography-derived physiology guidance (QFR®) to local routine diagnostic procedure (LRDP) and usual care in an all-comers patient population undergoing PCI with unrestrictive use of the Sinomed HT SUPREME™ sirolimus-eluting stent.
For the latest updates, please refer to the website of CORRIB Corelab (https://www.universityofgalway.ie/corrib-corelab/).
We wish the Pioneer-IV team and participants much success and look forward to the future results!
Share this article on: